Charles Dorland, OD in Minnetonka, MN - Medicare Optometry Provider

Charles Dorland, OD is a medicare enrolled "Optometrist" provider in Minnetonka, Minnesota. He went to Ohio State University - College Of Optometry and graduated in 1985 and has 39 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Park Nicollet Clinic and his current practice location is 15111 Twelve Oaks Center Dr, Minnetonka, Minnesota. You can reach out to his office (for appointments etc.) via phone at (952) 993-4500.

Charles Dorland is licensed to practice in Minnesota (license number 2028) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1104800804.

Contact Information

	Charles Dorland, OD
	15111 Twelve Oaks Center Dr, Minnetonka, MN 55305-5201
	(952) 993-4500
	Not Available

Healthcare Provider's Profile

Full Name	Charles Dorland
Gender	Male
Speciality	Optometry
Experience	39 Years
Location	15111 Twelve Oaks Center Dr, Minnetonka, Minnesota
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Charles Dorland attended and graduated from Ohio State University - College Of Optometry in 1985

NPI Data:

NPI Number: 1104800804
Provider Enumeration Date: 12/06/2005
Last Update Date: 02/29/2016

Medicare PECOS Information:

PECOS PAC ID: 8426184169
Enrollment ID: I20100331001250

Medical Identifiers

Medical identifiers for Charles Dorland such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104800804	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	2028 (Minnesota)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Park Nicollet Clinic	7911819438	1529

News Archive

WHO report says rich must stop poaching medical staff from poor

A critical shortage of doctors and nurses is causing unnecessary disease and death across much of the developing world as rich nations poach health-care workers.

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Researchers from Massachusetts Eye and Ear have, for the first time, identified rapidly proliferating cells (known as "neural crest-derived progenitor cells") in the corneal endothelium of specimens from normal corneas and from corneas with Fuchs' Endothelial Corneal Dystrophy (FECD), a condition in which the cells responsible for keeping the cornea clear die prematurely — often leading to blindness.

Physical activity teaching in UK medical schools virtually "non-existent"

UK medical school teaching on physical activity is "sparse or non-existent," finds research published online in the British Journal of Sports Medicine.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Charles Dorland allows following entities to bill medicare on his behalf.

Provider Name	Park Nicollet Clinic
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046

News Archive

WHO report says rich must stop poaching medical staff from poor

A critical shortage of doctors and nurses is causing unnecessary disease and death across much of the developing world as rich nations poach health-care workers.

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Physical activity teaching in UK medical schools virtually "non-existent"

UK medical school teaching on physical activity is "sparse or non-existent," finds research published online in the British Journal of Sports Medicine.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Charles Dorland is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Charles Dorland, OD 8170 33rd Ave S, Po Box 1309 Mail Stop 21110q, Minneapolis, MN 55425-4516 Ph: (952) 993-4500	Charles Dorland, OD 15111 Twelve Oaks Center Dr, Minnetonka, MN 55305-5201 Ph: (952) 993-4500

News Archive

WHO report says rich must stop poaching medical staff from poor

A critical shortage of doctors and nurses is causing unnecessary disease and death across much of the developing world as rich nations poach health-care workers.

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Physical activity teaching in UK medical schools virtually "non-existent"

UK medical school teaching on physical activity is "sparse or non-existent," finds research published online in the British Journal of Sports Medicine.

Optometrist in Minnetonka, MN

Hoffman Eyecare, P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12455 Ridgedale Dr, Ste 101, Minnetonka, MN 55305 Phone: 952-545-6010 Fax: 952-525-0999
Pearle Vision Optometrist Medicare: Medicare Enrolled Practice Location: 1601 Plymouth Rd, Minnetonka, MN 55305 Phone: 952-546-4414 Fax: 952-541-0831
Jay R Olson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12511 Wayzata Blvd, Ridgedale Center, Minnetonka, MN 55305 Phone: 952-591-1970 Fax: 952-591-1972
Dr. Joseph Max Kostecki, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4848 County Road 101, Minnetonka, MN 55345 Phone: 952-401-9202 Fax: 952-401-9379
John Joseph Perszyk, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 12577 Wayzata Blvd, Pearle Express / Ridgedale, Minnetonka, MN 55305 Phone: 952-546-4414 Fax: 952-541-0831
Emily Nelsen, OD Optometrist Medicare: Medicare Enrolled Practice Location: 13889 Ridgedale Dr, Minnetonka, MN 55305 Phone: 763-241-1090 Fax: 763-241-1091

Charles Dorland, OD - Medicare Optometrist in Minnetonka, MN

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

WHO report says rich must stop poaching medical staff from poor

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Physical activity teaching in UK medical schools virtually "non-existent"

Medicare Reassignments

WHO report says rich must stop poaching medical staff from poor

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Physical activity teaching in UK medical schools virtually "non-existent"

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

WHO report says rich must stop poaching medical staff from poor

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Research findings hold promise for new therapies using proliferating cells to treat patients with FECD

Physical activity teaching in UK medical schools virtually "non-existent"

Optometrist in Minnetonka, MN